Cellebrite DI Ltd. (CLBT)
NASDAQ: CLBT · Real-Time Price · USD
20.90
-0.11 (-0.53%)
Dec 5, 2024, 2:04 PM EST - Market open

Cellebrite DI Statistics

Total Valuation

Cellebrite DI has a market cap or net worth of $4.59 billion. The enterprise value is $4.18 billion.

Market Cap 4.59B
Enterprise Value 4.18B

Important Dates

The last earnings date was Wednesday, November 6, 2024, before market open.

Earnings Date Nov 6, 2024
Ex-Dividend Date n/a

Share Statistics

Cellebrite DI has 218.19 million shares outstanding. The number of shares has increased by 6.38% in one year.

Current Share Class 218.19M
Shares Outstanding 218.19M
Shares Change (YoY) +6.38%
Shares Change (QoQ) +4.90%
Owned by Insiders (%) 2.98%
Owned by Institutions (%) 37.30%
Float 91.42M

Valuation Ratios

PE Ratio n/a
Forward PE 56.03
PS Ratio 10.90
Forward PS 10.10
PB Ratio 14.70
P/TBV Ratio 17.82
P/FCF Ratio 44.97
P/OCF Ratio 41.84
PEG Ratio 2.21
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 62.27, with an EV/FCF ratio of 40.85.

EV / Earnings n/a
EV / Sales 10.86
EV / EBITDA 62.27
EV / EBIT 74.46
EV / FCF 40.85

Financial Position

The company has a current ratio of 1.84, with a Debt / Equity ratio of 0.04.

Current Ratio 1.84
Quick Ratio 1.70
Debt / Equity 0.04
Debt / EBITDA 0.17
Debt / FCF 0.12
Interest Coverage 0.22

Financial Efficiency

Return on equity (ROE) is -188.50% and return on invested capital (ROIC) is 19.48%.

Return on Equity (ROE) -188.50%
Return on Assets (ROA) 6.35%
Return on Capital (ROIC) 19.48%
Revenue Per Employee $382,110
Profits Per Employee -$314,408
Employee Count 1,008
Asset Turnover 0.70
Inventory Turnover 5.72

Taxes

In the past 12 months, Cellebrite DI has paid $8.70 million in taxes.

Income Tax 8.70M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +149.53% in the last 52 weeks. The beta is 1.51, so Cellebrite DI's price volatility has been higher than the market average.

Beta (5Y) 1.51
52-Week Price Change +149.53%
50-Day Moving Average 18.38
200-Day Moving Average 14.10
Relative Strength Index (RSI) 71.87
Average Volume (20 Days) 1,849,226

Short Selling Information

The latest short interest is 1.75 million, so 0.80% of the outstanding shares have been sold short.

Short Interest 1.75M
Short Previous Month 1.51M
Short % of Shares Out 0.80%
Short % of Float 1.91%
Short Ratio (days to cover) 1.22

Income Statement

In the last 12 months, Cellebrite DI had revenue of $385.17 million and -$316.92 million in losses. Loss per share was -$1.59.

Revenue 385.17M
Gross Profit 325.28M
Operating Income 56.18M
Pretax Income -106.25M
Net Income -316.92M
EBITDA 67.17M
EBIT 56.18M
Loss Per Share -$1.59
Full Income Statement

Balance Sheet

The company has $370.76 million in cash and $12.27 million in debt, giving a net cash position of $401.32 million or $1.84 per share.

Cash & Cash Equivalents 370.76M
Total Debt 12.27M
Net Cash 401.32M
Net Cash Per Share $1.84
Equity (Book Value) 298.32M
Book Value Per Share 1.43
Working Capital 228.53M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $110.03 million and capital expenditures -$7.65 million, giving a free cash flow of $102.38 million.

Operating Cash Flow 110.03M
Capital Expenditures -7.65M
Free Cash Flow 102.38M
FCF Per Share $0.47
Full Cash Flow Statement

Margins

Gross margin is 84.45%, with operating and profit margins of 14.59% and -82.28%.

Gross Margin 84.45%
Operating Margin 14.59%
Pretax Margin -80.02%
Profit Margin -82.28%
EBITDA Margin 17.44%
EBIT Margin 14.59%
FCF Margin 26.58%

Dividends & Yields

Cellebrite DI does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -6.38%
Shareholder Yield -6.38%
Earnings Yield -6.88%
FCF Yield 2.22%
Dividend Details

Analyst Forecast

The average price target for Cellebrite DI is $19.25, which is -8.55% lower than the current price. The consensus rating is "Strong Buy".

Price Target $19.25
Price Target Difference -8.55%
Analyst Consensus Strong Buy
Analyst Count 9
Revenue Growth Forecast (5Y) 15.31%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Cellebrite DI has an Altman Z-Score of 5 and a Piotroski F-Score of 5.

Altman Z-Score 5
Piotroski F-Score 5